Technology
Health
Biotechnology

ProQR Therapeutics

1,491

$7.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (+9.28%) Today
+$0.52 (+7.24%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell PRQR and other stocks, options, ETFs, and crypto commission-free!

About PRQR

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. Read More The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

CEO
Daniel Anton de Boer
Employees
—
Headquarters
Leiden, Zuid-Holland
Founded
2012
Market Cap
293.73M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
207.85K
High Today
$7.54
Low Today
$6.06
Open Price
$6.06
Volume
250.37K
52 Week High
$16.07
52 Week Low
$4.83

Collections

Technology
Health
Biotechnology
Therapy
Biopharmaceutical
Pharmaceutical
2014 IPO
Europe (Non-UK)

PRQR Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, Pre-Market

People Also Bought

Viking Therapeutics

49,748

$4.75

-1.86%

Viking Therapeutics

49,748

$4.75

-1.86%

Myovant Sciences

5,067

$7.75

-4.44%

Inovio

208,169

$8.72

+21.96%

CannTrust

117,288

$0.70

-5.41%

You May Also Like

MUE
NVGS
OSG
JKJ
GSIE
BIP
MSI
WFTBF
VRTS
EGP
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy PRQR

Market Price$7.70
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell PRQR stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up